IMPACT - Integrative Medicine PrimAry Care Trial: Protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Herman, Patricia M ^a   Dodds, Sally E ^b   Logue, Melanie D ^c,d   Abraham, Ivo ^d   Rehfeld, Rick A ^d   Grizzle, Amy J ^d   Urbine, Terry F ^d   Horwitz, Randy ^b   Crocker, Robert L ^b   Maizes, Victoria H ^b  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF NURSING   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Comparative effectiveness research; Complex interventions; Cost outcomes; Fidelity monitoring; Health services research; Healthcare utilization; Implementation fidelity; Integrative medicine; Observational study; Study protocol

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL; HUMAN; INTEGRATIVE MEDICINE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SELF REPORT; SEMI STRUCTURED INTERVIEW; UNITED STATES; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PRIMARY HEALTH CARE; PROCEDURES;

ADULT; AMBULATORY CARE FACILITIES; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTEGRATIVE MEDICINE; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 84899059874     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-132     Document Type: Article

References (85)

1. Maizes V, Schneider C, Bell I, Weil A. Integrative medical education: development and implementation of a comprehensive curriculum at the University of Arizona. Academ Med 2002, 77(9):851-860.
2. Boon H, Verhoef M, O'Hara D, Findlay B, Majid N. Integrative healthcare: arriving at a working definition. Alternative therapies in health and medicine 2004, 10(5):48.
3. About Us: Definition of Integrative Medicine [http://www.imconsortium.org/about/home.html], About Us: Definition of Integrative Medicine.
4. What is Complementary and Alternative Medicine? [http://nccam.nih.gov/health/whatiscam], What is Complementary and Alternative Medicine?.
5. What is integrative medicine? [http://www.bravewell.org/integrative_medicine/what_is_IM/], What is integrative medicine?.
6. Horrigan B, Lewis S, Abrams D, Pechura C. Integrative Medicine in America 2012, The Bravewell Collaborative: Minneapolis, MN.
7. Deng G, Weber W, Sood A, Kemper KJ. Research on integrative healthcare: context and priorities. Explore: The Journal of Science and Healing 2010, 6(3):143-158.
8. Deng G, Weber W, Sood A, Kemper K. Integrative Healthcare Research: Context and Priorities 2009, Institute of Medicine: Washington, DC.
9. Khorsan R, Coulter ID, Crawford C, Hsiao AF. Systematic review of integrative health care research: randomized control trials, clinical controlled trials, and meta-analysis. Evidence-Based Complementary and Alternative Medicine 2011, 2010.
10. Marcus DM, McCullough L. An evaluation of the evidence in" evidence-based" integrative medicine programs. Academic Medicine 2009, 84(9):1229. 10.1097/ACM.0b013e3181b185f4, 19707062.
11. Guarneri E, Horrigan BJ, Pechura CM. The efficacy and cost effectiveness of integrative medicine: a review of the medical and corporate literature. Explore: The Journal of Science and Healing 2010, 6(5):308.
12. Coulter ID, Khorsan R, Crawford C, Hsiao AF. Integrative health care under review. 2010,
13. Cassidy CM. Social science theory and methods in the study of alternative and complementary medicine. The Journal of Alternative and Complementary Medicine 1995, 1(1):19-40. 10.1089/acm.1995.1.19, 9395601.
14. Nahin RL, Straus SE. Research into complementary and alternative medicine: problems and potential. BMJ 2001, 322(7279):161-164. 10.1136/bmj.322.7279.161, 1119420, 11159578.
15. Mason S, Tovey P, Long AF. Evaluating complementary medicine: methodological challenges of randomised controlled trials. BMJ 2002, 325(7368):832-834. 10.1136/bmj.325.7368.832, 1124333, 12376448.
16. Harlan WR. New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health. J Alternative & Complemen Med 2001, 7(1):53-59.
17. Gatchel R, Maddrey A. Clinical outcome research in complementary and alternative medicine: an overview of experimental design and analysis. Alternative Ther Health Med 1998, 4(5):36.
18. Vickers A, Cassileth B, Ernst E, Fisher P, Goldman P, Jonas W, Kang S, Lewith G, Schulz K, Silagy C. How should we research unconventional therapies. Int J Technol Assess Health Care 1997, 13:111-121. 10.1017/S0266462300010278, 9119619.
19. Levin JS, Glass TA, Kushi LH, Schuck JR, Steele L, Jonas WB. Quantitative methods in research on complementary and alternative medicine: a methodological manifesto. Medical Care 1997, 35(11):1079-1094. 10.1097/00005650-199711000-00001, 9366888.
20. Vickers A. Methodological issues in complementary and alternative medicine research: a personal reflection on 10 years of debate in the United Kingdom. J Alternative Complementary Med 1996, 2(4):515-524.
21. Alexander JA, Hearld LR. Methods and metrics challenges of delivery-system research. Implementation Science 2012, 7(1):15. 10.1186/1748-5908-7-15, 3317852, 22409885.
22. Hasson H. Systematic evaluation of implementation fidelity of complex interventions in health and social care. Implement Sci 2010, 5(1):67. 10.1186/1748-5908-5-67, 2942793, 20815872.
23. Dumas JE, Lynch AM, Laughlin JE, Phillips Smith E, Prinz RJ. Promoting intervention fidelity: conceptual issues, methods, and preliminary results from the EARLY ALLIANCE prevention trial. Am J Preven Med 2001, 20(1):38-47.
24. Santacroce SJ, Maccarelli LM, Grey M. Intervention fidelity. Nursing Res 2004, 53(1):63-66.
25. Herman PM. Evaluating the Economics of Complementary and Integrative Medicine 2012, Samueli Institute: Alexandria, VA.
26. Rees L, Weil A. Integrated medicine: imbues orthodox medicine with the values of complementary medicine. BMJ 2001, 322(7279):119. 10.1136/bmj.322.7279.119, 1119398, 11159553.
27. Maizes V, Rakel D, Niemiec C. Integrative medicine and patient-centered care. In: IOM Summit on Integrative Medicine and the Health of the Public commissioned paper 2009, Institute of Medicine: Washington, DC.
28. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new medical research council guidance. BMJ 2008, 337.
29. Bell IR, Caspi O, Schwartz GER, Grant KL, Gaudet TW, Rychener D, Maizes V, Weil A. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Arch Int Med 2002, 162(2):133.
30. Ritenbaugh C, Verhoef M, Fleishman S, Boon H, Leis A. Whole systems research: a discipline for studying complementary and alternative medicine. Altern Ther Health Med 2003, 9(4):32.
31. Bond GR, Evans L, Salyers MP, Williams J, Kim HW. Measurement of fidelity in psychiatric rehabilitation. Ment Health Serv Res 2000, 2:75-87. 10.1023/A:1010153020697, 11256719.
32. Sechrest L, West SG, Phillips MA, Redner R, Yeaton W. Some neglected problems in evaluation research: strength and integrity of treatments. Evaluation Studies Review Annual 1979, 4:15-35.
33. Woolf SH, Johnson RE. Inattention to the fidelity of health care delivery is costing lives. Am J Public Health 2007, 97(10):1732.
34. Adler SR. Integrative medicine and culture: toward an Anthropology of CAM. Med Anthro Quart 2002, 16(4):412.
35. Long AF. Outcome measurement in complementary and alternative medicine: unpicking the effects. J Altern Complement Med 2002, 8(6):777-786. 10.1089/10755530260511793, 12614531.
36. Coulter ID, Khorsan R. Complementary alternative and integrative medicine: current challenges for outcomes measurement. Outcome Measurement in the Human Services 2011, 163-178. Washington, DC: NASW Press, Magnabosco JL, Manderscheid RW.
37. Federal Coordinating Council for Comparative Effectiveness Research Report to the President and the Congress 2009, Washington, DC: Federal Coordinating Council for Comparative Effectiveness Research, Federal Coordinating Council for Comparative Effectiveness Research.
38. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. New England J Med 2000, 342(25):1878-1886.
39. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England J Med 2000, 342(25):1887-1892.
40. Heinsman DT, Shadish WR. Assignment methods in experimentation: When do nonrandomized experiments approximate answers from randomized experiments?. Psychological Methods 1996, 1(2):154.
41. Tunis SR, Benner J, McClellan M. Comparative effectiveness research: policy context, methods development and research infrastructure. Statistics Med 2010, 29(19):1963-1976.
42. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: asking the right questions, choosing the right method. Health Affairs 2005, 24(1):128-132. 10.1377/hlthaff.24.1.128, 15647223.
43. Chokshi DA, Avorn J, Kesselheim AS. Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature. Health Affairs 2010, 29(10):1842-1848. 10.1377/hlthaff.2010.0843, 20921484.
44. Maizes V, Caspi O. The principles and challenges of integrative medicine. Western J Med 1999, 171(3):148.
45. Committee on the Future of Primary Care Primary Care: America's Health in a New Era 1996, Washington, DC: Institute of Medicine, Donaldson MS, Yordy KD, Lohr KN, Vanselow NA, Committee on the Future of Primary Care.
46. The defining principles of integrative medicine [http://integrativemedicine.arizona.edu/about/definition.html], The defining principles of integrative medicine.
47. Joint Principles of the Patient-Centered Medical Home [http://www.pcpcc.net/content/joint-principles-patient-centered-medical-home], Joint Principles of the Patient-Centered Medical Home.
48. Dodds SE, Herman PM, Sechrest L, Abraham I, Logue MD, Grizzle AL, Rehfeld RA, Urbine TJ, Horwitz R, Crocker RL, Maizes VH. When a whole practice model is the intervention: developing fidelity evaluation components using program theory-driven science for an integrative medicine primary care clinic. Evidence-Based Complementary and Alternative Medicine 2013, 2013(Article ID 652047):11.
49. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surveys 2008, 22(1):31-72.
50. Adult Visit Questionnaire 2.0 [http://cahps.ahrq.gov/clinician_group/], Adult Visit Questionnaire 2.0.
51. Behavioral Risk Factor Surveillance System Survey Questionnaire [http://www.cdc.gov/brfss], Behavioral Risk Factor Surveillance System Survey Questionnaire.
52. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Services Res 2004, 39(4p1):1005-1026.
53. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Services Res 2005, 40(6p1):1918-1930.
54. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Social Behavior 1983, 24:385-396.
55. Littman AJ, White E, Satia JA, Bowen DJ, Kristal AR. Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology 2006, 17(4):398-403. 10.1097/01.ede.0000219721.89552.51, 16641618.
56. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213. 10.1016/0165-1781(89)90047-4, 2748771.
57. Hargraves JL, Hays RD, Cleary PD. Psychometric properties of the consumer assessment of health plans study (CAHPS®) 2.0 adult core survey. Health Services Res 2003, 38(6p1):1509-1528.
58. Huskisson E. Measurement of pain. The Lancet 1974, 304(7889):1127-1131.
59. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology 1989, 46(10):1121. 10.1001/archneur.1989.00520460115022, 2803071.
60. Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire-2: validity of a two-item depression screener. Medical Care 2003, 41(11):1284-1292. 10.1097/01.MLR.0000093487.78664.3C, 14583691.
61. Kroenke K, Spitzer RL, Williams J, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Int Med 2007, 146(5):317. 10.7326/0003-4819-146-5-200703060-00004, 17339617.
62. Ware JE, Kosinski M, Keller SD. A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34(3):220-233. 10.1097/00005650-199603000-00003, 8628042.
63. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five well-being scale. Int J Methods Psychiatric Res 2003, 12(2):85-91.
64. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993, 4:353-353. 10.2165/00019053-199304050-00006, 10146874.
65. Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of health care utilization compared to provider records. J Clin Epidemiol 2001, 54(2):136-141. 10.1016/S0895-4356(00)00261-4, 11166528.
66. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 2009, 11(4):120. 10.1186/ar2734, 2745773, 19664170.
67. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals 2002, 32(9):509-515.
68. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Int Med 2001, 16(9):606-613.
69. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Int Med 2006, 166(10):1092.
70. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care. Circulation 2008, 117(6):743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
71. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. American Heart J 1991, 121(1):293-298.
72. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opinion Cardiol 2006, 21(1):1.
73. Safran DG, Karp M, Coltin K, Chang H, Li A, Ogren J, Rogers WH. Measuring patients' experiences with individual primary care physicians. J Gen Int Med 2006, 21(1):13-21.
74. Mercer SW, Maxwell M, Heaney D, Watt GCM. The consultation and relational empathy (CARE) measure: development and preliminary validation and reliability of an empathy-based consultation process measure. Family Practice 2004, 21(6):699-705. 10.1093/fampra/cmh621, 15528286.
75. Loo R, Loewen P. A confirmatory factor-analytic and psychometric examination of the team climate inventory full and short versions. Small Group Research 2002, 33(2):254-265.
76. Rohland BM, Kruse GR, Rohrer JE. Validation of a single-item measure of burnout against the Maslach Burnout Inventory among physicians Stress and Health 2004, 20(2):75-79.
77. National Center for Health Statistics Ambulatory Health Care Data 2012, Centers for Disease Control and Prevention, National Center for Health Statistics.
78. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Medical Care 2004, 42(9):851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
79. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Hillsdale, New Jersey: Lawrence Erlbaum Associates, 2.
80. Heo M, Faith MS, Mott JW, Gorman BS, Redden DT, Allison DB. Hierarchical linear models for the development of growth curves: an example with body mass index in overweight/obese adults. Stat Med 1911-1942, 2003:22.
81. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods, Second Edition edn 2002, Thousand Oaks, CA: Sage Publications.
82. Singer JD. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth curve models. J Educ Behav Stat 1998, 24(4):323-355.
83. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000, 19:3219-3236. 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P, 11113956.
84. Efron B, Tibshirani RJ. An Introduction to the Bootstrap 1994, Champman & Hall/CRC: Boca Raton.
85. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prevent Med 2007, 45(4):247-251.